Mercury Systems (MRCY) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
19 Nov, 2025Executive summary
Q3 FY25 revenue reached $211.4 million, up 1.5% year-over-year, with year-to-date revenue growth of 8.9%.
Backlog increased 4% year-over-year to $1.34 billion, with a trailing twelve-month book-to-bill ratio of 1.1.
Adjusted EBITDA was $24.7 million (11.7% margin), up from $(2.4) million last year; adjusted EPS improved to $0.06 from $(0.26).
Free cash flow for Q3 was $24.1 million, a $50 million improvement year-over-year.
Net loss for Q3 narrowed to $19.2 million from $44.6 million last year, aided by cost controls and workforce reductions.
Financial highlights
Q3 FY25 revenue: $211.4 million; nine-month revenue: $638.9 million.
Q3 FY25 gross margin: 27.0% (up 750 bps year-over-year); nine-month gross margin: 26.6%.
Q3 FY25 adjusted EBITDA: $24.7 million; nine-month adjusted EBITDA: $68.2 million.
Q3 FY25 adjusted EPS: $0.06; nine-month adjusted EPS: $0.17.
Cash and equivalents at quarter-end: $269.8 million; net debt at $322 million, lowest since Q1 FY22.
Outlook and guidance
FY25 revenue growth expected to approach mid-single digits year-over-year.
Q4 adjusted EBITDA margin anticipated to be the highest of the year, approaching mid-teens.
Full-year free cash flow projected above prior expectations, with $85 million generated year-to-date.
No specific FY26 guidance yet; commentary to be provided next quarter.
Management expects existing cash, revolver, and operations to cover anticipated needs for at least the next 12 months.
Latest events from Mercury Systems
- Record backlog and strong cash flow highlight momentum and growth in defense technology.MRCY
Investor presentation16 Mar 2026 - Record backlog and margin expansion drive Q2 growth, improved profitability, and strong outlook.MRCY
Q2 20264 Feb 2026 - Record backlog and free cash flow support margin expansion and growth in FY25.MRCY
Q4 20241 Feb 2026 - Revenue up 13%, bookings up 29%, record backlog, and improved margins with positive outlook.MRCY
Q1 202516 Jan 2026 - Q2 FY25 saw 13% revenue growth, record free cash flow, and improved margins.MRCY
Q2 20259 Jan 2026 - Director elections, executive pay, new incentive plan, and auditor ratification headline the agenda.MRCY
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, with enhanced focus on pay-for-performance and ESG.MRCY
Proxy Filing1 Dec 2025 - Record bookings, margin expansion, and strong free cash flow set the stage for FY26 growth.MRCY
Q4 202523 Nov 2025 - Revenue up 10.2% with record backlog, margin gains, and $200M buyback program announced.MRCY
Q1 202613 Nov 2025